Zhi-Qing David Xu

Zhi-Qing David Xu

Auto-generated profile, based on publicly available information

Zhi-Qing David Xu

Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Department of Pathology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2000 in Neuropharmacology
Verified
Journal Article
Closed access
THTomas Hökfelt
Tomas Hökfelt
CBChristian Broberger
Christian Broberger
ZXZhi-Qing David Xu
Zhi-Qing David Xu
VSValeriy Sergeyev
Valeriy Sergeyev
RURuud Ubink
Ruud Ubink
MDMargarita Diez
Margarita Diez

29 June 2010 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
WFWenyu Fu
Wenyu Fu
EMErwan Le Maître
Erwan Le Maître
VFVeronique Fabre
Veronique Fabre
JBJean‐Francois Bernard
Jean‐Francois Bernard
ZXZhi‐Qing David Xu
Zhi‐Qing David Xu
THTomas Hökfelt
Tomas Hökfelt

1 May 2002 in Neuroscience
Verified
Journal Article
Closed access
JKJ Kopp
J Kopp
ZXZ.-Q Xu
Z.-Q Xu
XZX Zhang
X Zhang
TPT Pedrazzini
T Pedrazzini
HHH Herzog
H Herzog
THT Hökfelt
T Hökfelt

15 November 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CSChad J. Swanson
Chad J. Swanson
TBThomas P. Blackburn
Thomas P. Blackburn
XZXuexiang Zhang
Xuexiang Zhang
KZKang Zheng
Kang Zheng
ZXZhi-Qing David Xu
Zhi-Qing David Xu
TBTheresa A. Branchek
Theresa A. Branchek
The neuropeptide galanin mediates its effects through the receptor subtypes Gal 1 , Gal 2 , and Gal 3 and has been implicated in anxiety- and depression-related behaviors. Nevertheless, the receptor subtypes relevant to these behaviors are not known because of the lack of available galanin-selective ligands. In this article, we use behavioral, neurochemical, and electrophysiological approaches to investigate the anxiolytic- and antidepressant-like effects of two potent small-molecule, Gal 3 -selective antagonists, SNAP 37889 and the more soluble analog SNAP 398299. Acute administration of SNAP 37889 or SNAP 398299 enhanced rat social interaction. Furthermore, acute SNAP 37889 was also shown to reduce guinea pig vocalizations after maternal separation, to attenuate stress-induced hyperthermia in mice, to increase punished drinking in rats, and to decrease immobility and increase swimming time during forced swim tests with rats. Moreover, SNAP 37889 increased the social interaction time after 14 days of treatment and maintained its antidepressant effects during forced swim tests with rats after 21 days of treatment. In microdialysis studies, SNAP 37889 partially antagonized the galanin-evoked reduction in hippocampal serotonin (5-hydroxytryptamine, 5-HT), as did the 5-HT 1A receptor antagonist WAY100635. Their combination produced a complete reversal of the effect of galanin. SNAP 398299 partially reversed the galanin-evoked inhibition of dorsal raphe cell firing and galanin-evoked hyperpolarizing currents. These results indicate that Gal 3 -selective antagonists produce anxiolytic- and antidepressant-like effects, possibly by attenuating the inhibitory influence of galanin on 5-HT transmission at the level of the dorsal raphe nucleus.

1 February 1995 in Neuroscience
Verified
Journal Article
Closed access
VPV.A. Pieribone
V.A. Pieribone
ZXZ.-Q. Xu
Z.-Q. Xu
XZX. Zhang
X. Zhang
SGS. Grillner
S. Grillner
TBT. Bartfai
T. Bartfai
THT. Hökfelt
T. Hökfelt